Skip to content
PICO Portalanswers from OpenAlex

Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease

PaperCitations, authors & open-access status

Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease have?

PICO Portalcitation count

Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease has 3 citations in the OpenAlex counts PICO Portal stores.

When was Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease published?

PICO Portalyear

Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease has 2025 year in the PICO Portal index.

What is the open-access status of Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease?

PICO Portaloa status

Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease has closed oa status in the PICO Portal index.

What is the DOI of Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease?

PICO Portaldoi

The DOI for Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease is on the source record.

What is the PMID of Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease?

PICO Portalpmid

The PMID for Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease is on the source record.

What is the OpenAlex record for Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease?

PICO Portalopenalex

The OpenAlex for Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial